androstenedione has been researched along with Adenocarcinoma, Endometrioid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Almås, B; Bertelsen, BE; Fasmer, KE; Forsse, D; Haldorsen, IS; Halle, MK; Krakstad, C; Tangen, IL; Trovik, J; Viste, K | 1 |
Abbink, K; Bulten, J; Küsters-Vandevelde, HVN; Massuger, LFAG; Pijnenborg, JMA; Reijnen, C; Snijders, MPLM; van der Laak, JAWM; van Herwaarden, AE; Zusterzeel, PLM | 1 |
Gama, R; Murphy, DJ; Salmons, N; Shearer, JL | 1 |
Heineman, MJ; Hollema, H; Jongen, VH; Santema, JG; van der Zee, AG | 1 |
Bennett, P; Blaakaer, J; Bock, J; Daugaard, S; Høgdall, CK; Hørding, U; Toftager-Larsen, K | 1 |
5 other study(ies) available for androstenedione and Adenocarcinoma, Endometrioid
Article | Year |
---|---|
Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Biomarkers, Tumor; Carcinoma, Endometrioid; Chromatography, Liquid; Cohort Studies; Cortodoxone; Endometrial Neoplasms; Estradiol; Estrogens; Estrone; Female; Gene Expression; Humans; Norway; RNA, Messenger; Signal Transduction; Tandem Mass Spectrometry | 2020 |
Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.
Topics: Aged; Aged, 80 and over; Androstenedione; Carcinoma, Endometrioid; Dehydroepiandrosterone Sulfate; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Leydig Cells; Male; Middle Aged; Ovary; Postmenopause; Retrospective Studies; Stromal Cells; Testosterone | 2019 |
Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Androstenedione; Biomarkers, Tumor; Carcinoma, Endometrioid; Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Inhibins; Ovarian Neoplasms; Postmenopause; Testosterone; Virilism | 2017 |
Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer.
Topics: Androstenedione; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Hyperplasia; Middle Aged; Ovary; Postmenopause; Prospective Studies; Retrospective Studies; Steroids; Testosterone; Veins | 2003 |
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aging; Androstenedione; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Progesterone; Prognosis; Regression Analysis; Testosterone | 1993 |